ModuLight.bio

Optogenetics-based Platform for Neuro-excitatory Conditions

Health Tech & Life Sciences
Active
Seed Ramat Gan Founded 2022
Website ↗
Total raised
$6.7M
Last: Seed 2025-07
Stage
Seed
Founded
2022
Headcount
31
HQ
Ramat Gan
Sector
Health Tech & Life Sciences

About

Modulight is developing an optogenetics-based platform for treating neuronal overactivation disorders, regardless of their specific underlying cause.

The company aims to revolutionize the treatment of severe neurological conditions for millions of people worldwide.

Funding history · 2 rounds · $6.7M total

2025-07
Seed Undisclosed
Date unknown
Seed $6.7M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

neuro-stimulationpharmaceuticalsneurology